CXCR4 and neoplasm: CTCE‐9908 (CXCR‐4 antagonist) is a 17‐amino acid sequenced peptide consisting of a dimer of eight amino acid N‐terminal sequences,75, 76 that has shown to inhibit adhesion and growth of tumour cells.77